← Open Payments lookup

ELISE TETELMAN: Open Payments

NPI 1225530686 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,630 in 108 payments from 30 companies in 2025. Trend: 2023 $218 · 2024 $583 · 2025 $4,630

Food & beverage: $4,630
CompanyPaymentsAmount
Incyte Corporation11$533
Regeneron Healthcare Solutions, Inc.3$369
CSL Behring8$360
AstraZeneca Pharmaceuticals LP4$277
Grifols USA, LLC5$267
Novartis Pharmaceuticals Corporation9$262
ARS Pharmaceuticals Operations, Inc.6$224
Amgen Inc.4$198
GlaxoSmithKline, LLC.6$197
Takeda Pharmaceuticals U.S.A., Inc.9$192

Products named: DUPIXENT, OPZELURA, Xembify, NEFFY, AYVAKIT, NEMLUVIO, NUCALA, Hizentra.

Industry payments across CA — which companies pay providers there.